{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:39:32Z","timestamp":1793320772472,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell'Istruzione, dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["20223WSTY4"],"award-info":[{"award-number":["20223WSTY4"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell'Istruzione, dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["202229X8hW"],"award-info":[{"award-number":["202229X8hW"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007364","name":"Fondazione CRT","doi-asserted-by":"publisher","award":["106459\/2023.1741"],"award-info":[{"award-number":["106459\/2023.1741"]}],"id":[{"id":"10.13039\/100007364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007364","name":"Fondazione CRT","doi-asserted-by":"publisher","award":["10683\/2023.1759"],"award-info":[{"award-number":["10683\/2023.1759"]}],"id":[{"id":"10.13039\/100007364","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beneficientia Stiftung Foundation"},{"name":"Local Research Funding (Department of Medical Sciences, University of Turin) (# RILO_24_01)."},{"name":"Veterans Affairs Department and University of Miami Miller School of Medicine."},{"name":"Medical Research Service of the Veterans Affairs Department and University of Miami Miller School of Medicine."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Alzheimer\u2019s disease (AD) is a progressive neurodegenerative disorder characterized by amyloid-\u03b2 (A\u03b2) accumulation, tau hyperphosphorylation, neuroinflammation, and synaptic loss. Existing therapies provide only modest symptomatic relief and fail to slow disease progression. Beyond its role in promoting pituitary growth hormone (GH) secretion, growth hormone-releasing hormone (GHRH) has shown neuroprotective effects in experimental ischemic stroke and spinal muscular atrophy. Here, we explored the therapeutic potential of GHRH and its agonist MR-409 in AD models. In vitro, GHRH(1-44)NH\u2082 promoted survival, proliferation, and neuronal differentiation of rat hippocampal neural stem cells (NSCs) and human SH-SY5Y neuroblastoma cells under growth factor deprivation and amyloid beta (A\u03b2)\n                    <jats:sub>1-42<\/jats:sub>\n                    exposure. These effects involved the cAMP\/PKA\/CREB, ERK1\/2, and PI3K\/Akt signaling pathways. GHRH also attenuated A\u03b2-induced neurotoxicity by reducing apoptosis, suppressing GSK-3\u03b2 activity and tau phosphorylation, restoring nuclear \u03b2-catenin, and inhibiting NF-\u03baB-mediated inflammation. In vivo, subcutaneous administration of MR-409 in 5xFAD mice reduced A\u03b2 deposition, tau phosphorylation, gliosis, and proinflammatory cytokine expression. In addition, MR-409 mitigated neuronal and synaptic loss, activated survival and neurogenic pathways, and improved cognitive performance, without altering systemic GH and IGF1 levels. MR-409 also elevated NRF2 mRNA expression while reducing its negative regulator KEAP1. Overall, these findings indicate that GHRH and its analog MR-409 exert neuroprotective effects by modulating key pathological features of AD, including neurodegeneration, impaired neurogenesis, neuroinflammation, and oxidative stress. Given their ability to modulate multiple pathological pathways, GHRH agonists may represent promising therapeutic candidates for AD and other neurodegenerative disorders.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-08699-w","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T04:54:56Z","timestamp":1775537696000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Growth hormone-releasing hormone attenuates amyloid deposition and neuroinflammation in Alzheimer\u2019s disease models"],"prefix":"10.1038","volume":"17","author":[{"given":"Francesca","family":"Pedrolli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Morello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4901-4764","authenticated-orcid":false,"given":"Iacopo","family":"Gesmundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Banfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7338-2041","authenticated-orcid":false,"given":"Medhi","family":"Wangpaichitr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4740-2325","authenticated-orcid":false,"given":"Wei","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Tamagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew V.","family":"Schally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Guglielmotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4164-7313","authenticated-orcid":false,"given":"Riccarda","family":"Granata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"8699_CR1","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen CE, et al. Alzheimer\u2019s disease. Lancet. 2021;397:1577\u201390.","journal-title":"Lancet"},{"key":"8699_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-020-00391-7","volume":"15","author":"T Guo","year":"2020","unstructured":"Guo T, Zhang D, Zeng Y, Huang TY, Xu H, Zhao Y. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer\u2019s disease. Mol Neurodegener. 2020;15:40.","journal-title":"Mol Neurodegener"},{"key":"8699_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer's disease: where do we go from here? Nat Rev Neurol. 2021;17:157\u201372.","journal-title":"Nat Rev Neurol"},{"key":"8699_CR4","doi-asserted-by":"crossref","unstructured":"De Deyn L, Sleegers K. The impact of rare genetic variants on Alzheimer's disease. Nat Rev Neurol. 2025;21:27\u201339.","DOI":"10.1038\/s41582-025-01062-1"},{"key":"8699_CR5","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM. Alzheimer's Disease: an update on pathobiology and treatment strategies. Cell. 2019;179:312\u201339.","journal-title":"Cell"},{"key":"8699_CR6","doi-asserted-by":"crossref","unstructured":"Sun E, Motolani A, Campos L, Lu T. The pivotal role of NF-kB in the pathogenesis and therapeutics of Alzheimer\u2019s disease. Int J Mol Sci. 2022;23:8972.","DOI":"10.3390\/ijms23168972"},{"key":"8699_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102033","volume":"90","author":"MG Fronza","year":"2023","unstructured":"Fronza MG, Alves D, Pratico D, Savegnago L. The neurobiology and therapeutic potential of multi-targeting beta-secretase, glycogen synthase kinase 3beta and acetylcholinesterase in Alzheimer\u2019s disease. Ageing Res Rev. 2023;90:102033.","journal-title":"Ageing Res Rev"},{"key":"8699_CR8","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s11064-021-03227-y","volume":"46","author":"X Liu","year":"2021","unstructured":"Liu X, Wang K, Wei X, Xie T, Lv B, Zhou Q, et al. Interaction of NF-kappaB and Wnt\/beta-catenin signaling pathways in Alzheimer\u2019s disease and potential active drug treatments. Neurochem Res. 2021;46:711\u201331.","journal-title":"Neurochem Res"},{"key":"8699_CR9","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1016\/j.cell.2023.08.021","volume":"186","author":"M Jucker","year":"2023","unstructured":"Jucker M, Walker LC. Alzheimer\u2019s disease: from immunotherapy to immunoprevention. Cell. 2023;186:4260\u201370.","journal-title":"Cell"},{"key":"8699_CR10","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1126\/science.6812220","volume":"218","author":"R Guillemin","year":"1982","unstructured":"Guillemin R, Brazeau P, Bohlen P, Esch F, Ling N, Wehrenberg WB. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science. 1982;218:585\u20137.","journal-title":"Science"},{"key":"8699_CR11","doi-asserted-by":"crossref","unstructured":"Liu Y, Fu R, Jia H, Yang K, Ren F, Zhou MS. GHRH and its analogues in central nervous system diseases. Rev Endocr Metab Disord. 2024;26:427\u201342.","DOI":"10.1007\/s11154-024-09920-x"},{"key":"8699_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2024.101161","volume":"76","author":"CA Hayes","year":"2025","unstructured":"Hayes CA, Wilson D, De Leon MA, Mustapha MJ, Morales S, Odden MC, et al. Insulin-like growth factor-1 and cognitive health: exploring cellular, preclinical, and clinical dimensions. Front Neuroendocrinol. 2025;76:101161.","journal-title":"Front Neuroendocrinol"},{"key":"8699_CR13","doi-asserted-by":"crossref","unstructured":"Bianchi VE, Locatelli V, Rizzi L. Neurotrophic and neuroregenerative effects of GH\/IGF1. Int J Mol Sci. 2017:18:2441.","DOI":"10.3390\/ijms18112441"},{"key":"8699_CR14","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1210\/en.2019-00111","volume":"160","author":"AV Schally","year":"2019","unstructured":"Schally AV, Zhang X, Cai R, Hare JM, Granata R, Bartoli M. Actions and potential therapeutic applications of growth hormone-releasing hormone agonists. Endocrinology. 2019;160:1600\u201312.","journal-title":"Endocrinology"},{"key":"8699_CR15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2216814120","volume":"120","author":"M Boido","year":"2023","unstructured":"Boido M, Gesmundo I, Caretto A, Pedrolli F, Schellino R, Leone S, et al. Agonist of growth hormone-releasing hormone improves the disease features of spinal muscular atrophy mice. Proc Natl Acad Sci USA. 2023;120:e2216814120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8699_CR16","doi-asserted-by":"crossref","unstructured":"Liu Y, Yang J, Che X, Huang J, Zhang X, Fu X, et al. Agonistic analog of growth hormone-releasing hormone promotes neurofunctional recovery and neural regeneration in ischemic stroke. Proc Natl Acad Sci USA. 2021;118:e2109600118.","DOI":"10.1073\/pnas.2109600118"},{"key":"8699_CR17","doi-asserted-by":"publisher","first-page":"R147","DOI":"10.1152\/ajpregu.00494.2009","volume":"298","author":"Z Peterfi","year":"2010","unstructured":"Peterfi Z, McGinty D, Sarai E, Szymusiak R. Growth hormone-releasing hormone activates sleep regulatory neurons of the rat preoptic hypothalamus. Am J Physiol Regul Integr Comp Physiol. 2010;298:R147\u201356.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"8699_CR18","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1001\/jamaneurol.2013.1425","volume":"70","author":"SD Friedman","year":"2013","unstructured":"Friedman SD, Baker LD, Borson S, Jensen JE, Barsness SM, Craft S, et al. Growth hormone-releasing hormone effects on brain gamma-aminobutyric acid levels in mild cognitive impairment and healthy aging. JAMA Neurol. 2013;70:883\u201390.","journal-title":"JAMA Neurol"},{"key":"8699_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18416-5","volume":"7","author":"S Tang","year":"2017","unstructured":"Tang S, Luo Z, Qiu X, Zhang Y, Lu X, Huang H, et al. Interactions between GHRH and GABAARs in the brains of patients with epilepsy and in animal models of epilepsy. Sci Rep. 2017;7:18110.","journal-title":"Sci Rep"},{"key":"8699_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.bbi.2014.09.005","volume":"47","author":"F Liao","year":"2015","unstructured":"Liao F, Zhang TJ, Mahan TE, Jiang H, Holtzman DM. Effects of growth hormone-releasing hormone on sleep and brain interstitial fluid amyloid-beta in an APP transgenic mouse model. Brain Behav Immun. 2015;47:163\u201371.","journal-title":"Brain Behav Immun"},{"key":"8699_CR21","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1001\/archneurol.2012.1970","volume":"69","author":"LD Baker","year":"2012","unstructured":"Baker LD, Barsness SM, Borson S, Merriam GR, Friedman SD, Craft S, et al. Effects of growth hormone-releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial. Arch Neurol. 2012;69:1420\u20139.","journal-title":"Arch Neurol"},{"key":"8699_CR22","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.neurobiolaging.2005.01.010","volume":"27","author":"MV Vitiello","year":"2006","unstructured":"Vitiello MV, Moe KE, Merriam GR, Mazzoni G, Buchner DH, Schwartz RS. Growth hormone-releasing hormone improves the cognition of healthy older adults. Neurobiol Aging. 2006;27:318\u201323.","journal-title":"Neurobiol Aging"},{"key":"8699_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.peptides.2013.12.010","volume":"52","author":"R Cai","year":"2014","unstructured":"Cai R, Schally AV, Cui T, Szalontay L, Halmos G, Sha W, et al. Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities. Peptides. 2014;52:104\u201312.","journal-title":"Peptides"},{"key":"8699_CR24","doi-asserted-by":"crossref","unstructured":"Schally AV, Cai R, Zhang X, Sha W, Wangpaichitr M. The development of growth hormone-releasing hormone analogs: Therapeutic advances in cancer, regenerative medicine, and metabolic disorders. Rev Endocr Metab Disord. 2025;26:385\u201396.","DOI":"10.1007\/s11154-024-09929-2"},{"key":"8699_CR25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41574-024-01052-1","volume":"21","author":"R Granata","year":"2025","unstructured":"Granata R, Leone S, Zhang X, Gesmundo I, Steenblock C, Cai R, et al. Growth hormone-releasing hormone and its analogues in health and disease. Nat Rev Endocrinol. 2025;21:180\u201395.","journal-title":"Nat Rev Endocrinol"},{"key":"8699_CR26","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/jnc.12360","volume":"127","author":"D Nair","year":"2013","unstructured":"Nair D, Ramesh V, Li RC, Schally AV, Gozal D. Growth hormone-releasing hormone (GHRH) signaling modulates intermittent hypoxia-induced oxidative stress and cognitive deficits in mouse. J Neurochem. 2013;127:531\u201340.","journal-title":"J Neurochem"},{"key":"8699_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-57292-z","volume":"10","author":"L Recinella","year":"2020","unstructured":"Recinella L, Chiavaroli A, Orlando G, Ferrante C, Marconi GD, Gesmundo I, et al. Antinflammatory, antioxidant, and behavioral effects induced by administration of growth hormone-releasing hormone analogs in mice. Sci Rep. 2020;10:732.","journal-title":"Sci Rep"},{"key":"8699_CR28","doi-asserted-by":"publisher","first-page":"13248","DOI":"10.1073\/pnas.1718592114","volume":"114","author":"MC Thounaojam","year":"2017","unstructured":"Thounaojam MC, Powell FL, Patel S, Gutsaeva DR, Tawfik A, Smith SB, et al. Protective effects of agonists of growth hormone-releasing hormone (GHRH) in early experimental diabetic retinopathy. Proc Natl Acad Sci USA. 2017;114:13248\u201353.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8699_CR29","doi-asserted-by":"publisher","first-page":"7355","DOI":"10.1007\/s12035-019-1605-3","volume":"56","author":"LM de Medeiros","year":"2019","unstructured":"de Medeiros LM, De Bastiani MA, Rico EP, Schonhofen P, Pfaffenseller B, Wollenhaupt-Aguiar B, et al. Cholinergic differentiation of human neuroblastoma SH-SY5Y cell line and its potential use as an in vitro model for Alzheimer\u2019s disease studies. Mol Neurobiol. 2019;56:7355\u201367.","journal-title":"Mol Neurobiol"},{"key":"8699_CR30","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26:10129\u201340.","journal-title":"J Neurosci"},{"key":"8699_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-021-01054-y","volume":"8","author":"S Forner","year":"2021","unstructured":"Forner S, Kawauchi S, Balderrama-Guti\u00e9rrez G, Kramar EA, Matheos DP, Phan J, et al. Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer\u2019s disease. Sci Data. 2021;8:270.","journal-title":"Sci Data"},{"key":"8699_CR32","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.286.5440.735","volume":"286","author":"R Vassar","year":"1999","unstructured":"Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, et al. Beta-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 1999;286:735\u201341.","journal-title":"Science"},{"key":"8699_CR33","doi-asserted-by":"crossref","unstructured":"Chu CT, Uruno A, Katsuoka F, Yamamoto M. Role of NRF2 in pathogenesis of Alzheimer\u2019s disease. Antioxidants. 2024;13:1529.","DOI":"10.3390\/antiox13121529"},{"key":"8699_CR34","doi-asserted-by":"crossref","unstructured":"Poon CH, Wong STN, Roy J, Wang YY, Chan HWH, Steinbusch H, et al. Sex differences between neuronal loss and the early onset of amyloid deposits and behavioral consequences in 5xFAD transgenic mouse as a model for Alzheimer\u2019s disease. Cell. 2023;12:780.","DOI":"10.3390\/cells12050780"},{"key":"8699_CR35","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.stem.2023.01.002","volume":"30","author":"E Salta","year":"2023","unstructured":"Salta E, Lazarov O, Fitzsimons CP, Tanzi R, Lucassen PJ, Choi SH. Adult hippocampal neurogenesis in Alzheimer\u2019s disease: a roadmap to clinical relevance. Cell Stem Cell. 2023;30:120\u201336.","journal-title":"Cell Stem Cell"},{"key":"8699_CR36","doi-asserted-by":"publisher","first-page":"12033","DOI":"10.1073\/pnas.1712612114","volume":"114","author":"I Gesmundo","year":"2017","unstructured":"Gesmundo I, Miragoli M, Carullo P, Trovato L, Larcher V, Di Pasquale E, et al. Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure. Proc Natl Acad Sci USA. 2017;114:12033\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8699_CR37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2209810120","volume":"120","author":"RA Louzada","year":"2023","unstructured":"Louzada RA, Blandino-Rosano M, Flores S, Lubaczeuski C, Cui T, Sha W, et al. GHRH agonist MR-409 protects beta-cells from streptozotocin-induced diabetes. Proc Natl Acad Sci USA. 2023;120:e2209810120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8699_CR38","doi-asserted-by":"crossref","unstructured":"Halmos G, Szabo Z, Dobos N, Juhasz E, Schally AV. Growth hormone-releasing hormone receptor (GHRH-R) and its signaling. Rev Endocr Metab Disord. 2025;26:343\u201352.","DOI":"10.1007\/s11154-025-09952-x"},{"key":"8699_CR39","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1007\/s43440-023-00526-9","volume":"75","author":"N Khakha","year":"2023","unstructured":"Khakha N, Khan H, Kaur A, Singh TG. Therapeutic implications of phosphorylation- and dephosphorylation-dependent factors of cAMP-response element-binding protein (CREB) in neurodegeneration. Pharmacol Rep. 2023;75:1152\u201365.","journal-title":"Pharmacol Rep"},{"key":"8699_CR40","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s12035-021-02611-7","volume":"59","author":"M Kumar","year":"2022","unstructured":"Kumar M, Bansal N. Implications of Phosphoinositide 3-Kinase-Akt (PI3K-Akt) Pathway in the Pathogenesis of Alzheimer\u2019s Disease. Mol Neurobiol. 2022;59:354\u201385.","journal-title":"Mol Neurobiol"},{"key":"8699_CR41","doi-asserted-by":"crossref","unstructured":"Albert-Gasc\u00f3 H, Ros-Bernal F, Castillo-G\u00f3mez E, Olucha-Bordonau FE. MAP\/ERK Signaling in developing cognitive and emotional function and its effect on pathological and neurodegenerative processes. Int J Mol Sci. 2020;21:4471.","DOI":"10.3390\/ijms21124471"},{"key":"8699_CR42","doi-asserted-by":"crossref","unstructured":"Numakawa T, Kajihara R. The Role of brain-derived neurotrophic factor as an essential mediator in neuronal functions and the therapeutic potential of its mimetics for neuroprotection in neurologic and psychiatric disorders. Molecules. 2025;30:848.","DOI":"10.3390\/molecules30040848"},{"key":"8699_CR43","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.4103\/1673-5374.262571","volume":"14","author":"A Bernabeu-Zornoza","year":"2019","unstructured":"Bernabeu-Zornoza A, Coronel R, Palmer C, Monteagudo M, Zambrano A, Liste I. Physiological and pathological effects of amyloid-beta species in neural stem cell biology. Neural Regen Res. 2019;14:2035\u201342.","journal-title":"Neural Regen Res"},{"key":"8699_CR44","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1210\/en.2007-0733","volume":"149","author":"I Johansson","year":"2008","unstructured":"Johansson I, Destefanis S, Aberg ND, Aberg MA, Blomgren K, Zhu C, et al. Proliferative and protective effects of growth hormone secretagogues on adult rat hippocampal progenitor cells. Endocrinology. 2008;149:2191\u20139.","journal-title":"Endocrinology"},{"key":"8699_CR45","doi-asserted-by":"publisher","first-page":"8558","DOI":"10.1002\/jcp.29699","volume":"235","author":"B Gong","year":"2020","unstructured":"Gong B, Jiao L, Du X, Li Y, Bi M, Jiao Q, et al. Ghrelin promotes midbrain neural stem cells differentiation to dopaminergic neurons through the Wnt\/beta-catenin pathway. J Cell Physiol. 2020;235:8558\u201370.","journal-title":"J Cell Physiol"},{"key":"8699_CR46","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1210\/EN.2015-1098","volume":"156","author":"D Gallo","year":"2015","unstructured":"Gallo D, Gesmundo I, Trovato L, Pera G, Gargantini E, Minetto MA, et al. GH-releasing hormone promotes survival and prevents TNF-alpha-induced apoptosis and atrophy in C2C12 myotubes. Endocrinology. 2015;156:3239\u201352.","journal-title":"Endocrinology"},{"key":"8699_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12929-020-0622-x","volume":"27","author":"Y Hayashi","year":"2020","unstructured":"Hayashi Y, Lin HT, Lee CC, Tsai KJ. Effects of neural stem cell transplantation in Alzheimer\u2019s disease models. J Biomed Sci. 2020;27:29.","journal-title":"J Biomed Sci"},{"key":"8699_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1102525","volume":"10","author":"HL Ren","year":"2023","unstructured":"Ren HL, Cai R, Xue R, Zhang Y, Xu Q, Zhang X, et al. Growth hormone-releasing hormone agonist attenuates vascular calcification in diabetic db\/db mice. Front Cardiovasc Med. 2023;10:1102525.","journal-title":"Front Cardiovasc Med"},{"key":"8699_CR49","doi-asserted-by":"publisher","first-page":"12028","DOI":"10.1073\/pnas.1813375115","volume":"115","author":"AV Schally","year":"2018","unstructured":"Schally AV, Wang H, He J, Cai R, Sha W, Popovics P, et al. Agonists of growth hormone-releasing hormone (GHRH) inhibit human experimental cancers in vivo by down-regulating receptors for GHRH. Proc Natl Acad Sci USA. 2018;115:12028\u201333.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8699_CR50","doi-asserted-by":"publisher","first-page":"28745","DOI":"10.18632\/oncotarget.25676","volume":"9","author":"T Cui","year":"2018","unstructured":"Cui T, Schally AV. Growth hormone-releasing hormone (GHRH) and its agonists inhibit hepatic and tumoral secretion of IGF-1. Oncotarget. 2018;9:28745\u201356.","journal-title":"Oncotarget"},{"key":"8699_CR51","doi-asserted-by":"publisher","first-page":"e0157384","DOI":"10.1371\/journal.pone.0157384","volume":"11","author":"M Venturelli","year":"2016","unstructured":"Venturelli M, Ce E, Limonta E, Muti E, Scarsini R, Brasioli A, et al. Possible predictors of involuntary weight loss in patients with Alzheimer\u2019s disease. PLoS ONE. 2016;11:e0157384.","journal-title":"PLoS ONE"},{"key":"8699_CR52","doi-asserted-by":"publisher","first-page":"196.e29","DOI":"10.1016\/j.neurobiolaging.2010.05.027","volume":"33","author":"S Jawhar","year":"2012","unstructured":"Jawhar S, Trawicka A, Jenneckens C, Bayer TA, Wirths O. Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer\u2019s disease. Neurobiol Aging. 2012;33:196.e29\u201340.","journal-title":"Neurobiol Aging"},{"key":"8699_CR53","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen H, Li R, Sterling K, Song W. Amyloid beta-based therapy for Alzheimer\u2019s disease: challenges, successes and future. Signal Transduct Target Ther. 2023;8:248.","journal-title":"Signal Transduct Target Ther"},{"key":"8699_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.964336","volume":"14","author":"KC Tsui","year":"2022","unstructured":"Tsui KC, Roy J, Chau SC, Wong KH, Shi L, Poon CH, et al. Distribution and inter-regional relationship of amyloid-beta plaque deposition in a 5xFAD mouse model of Alzheimer\u2019s disease. Front Aging Neurosci. 2022;14:964336.","journal-title":"Front Aging Neurosci"},{"key":"8699_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2020.118664","volume":"1867","author":"E Lauretti","year":"2020","unstructured":"Lauretti E, Dincer O, Pratico D. Glycogen synthase kinase-3 signaling in Alzheimer\u2019s disease. Biochim Biophys Acta Mol Cell Res. 2020;1867:118664.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"8699_CR56","doi-asserted-by":"crossref","unstructured":"Jeong YO, Shin SJ, Park JY, Ku BK, Song JS, Kim JJ, et al. MK-0677, a ghrelin agonist, alleviates amyloid beta-related pathology in 5XFAD Mice, an animal model of Alzheimer\u2019s disease. Int J Mol Sci. 2018;19:1800.","DOI":"10.3390\/ijms19061800"},{"key":"8699_CR57","doi-asserted-by":"crossref","unstructured":"Zhang L, Li J, Lin A. Assessment of neurodegeneration and neuronal loss in aged 5XFAD mice. STAR Protoc. 2021;2:100915.","DOI":"10.1016\/j.xpro.2021.100915"},{"key":"8699_CR58","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1515\/revneuro-2024-0110","volume":"36","author":"E Colin-Martinez","year":"2025","unstructured":"Colin-Martinez E, Arias C. Involvement of the VGF\/BDNF axis in the neuropathology of Alzheimer\u2019s disease and its potential role in diagnosis and treatment. Rev Neurosci. 2025;36:267\u201378.","journal-title":"Rev Neurosci"},{"key":"8699_CR59","doi-asserted-by":"publisher","first-page":"406","DOI":"10.21037\/atm-20-6561","volume":"9","author":"Y Chang","year":"2021","unstructured":"Chang Y, Huang R, Zhai Y, Huang L, Feng Y, Wang D, et al. A potentially effective drug for patients with recurrent glioma: sermorelin. Ann Transl Med. 2021;9:406.","journal-title":"Ann Transl Med"},{"key":"8699_CR60","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.2174\/1381612043384934","volume":"10","author":"D Dogrukol-Ak","year":"2004","unstructured":"Dogrukol-Ak D, Tore F, Tuncel N. Passage of VIP\/PACAP\/secretin family across the blood-brain barrier: therapeutic effects. Curr Pharm Des. 2004;10:1325\u201340.","journal-title":"Curr Pharm Des"},{"key":"8699_CR61","doi-asserted-by":"publisher","first-page":"12495","DOI":"10.1073\/pnas.0504163102","volume":"102","author":"LB Jaeger","year":"2005","unstructured":"Jaeger LB, Banks WA, Varga JL, Schally AV. Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: a potential applicability to treatment of brain tumors. Proc Natl Acad Sci USA. 2005;102:12495\u2013500.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8699_CR62","doi-asserted-by":"crossref","unstructured":"Cen LP, Ng TK, Liang JJ, Xu C, Zhuang X, Liu YF, et al. Agonist of growth hormone-releasing hormone enhances retinal ganglion cell protection induced by macrophages after optic nerve injury. Proc Natl Acad Sci USA. 2021;118:e1920834118.","DOI":"10.1073\/pnas.1920834118"},{"key":"8699_CR63","doi-asserted-by":"crossref","unstructured":"Liu Y, Huber CC, Wang H. Disrupted blood-brain barrier in 5xFAD mouse model of Alzheimer\u2019s disease can be mimicked and repaired in vitro with neural stem cell-derived exosomes. Biochem Biophys Res Commun. 2020;525:192\u201396.","DOI":"10.1016\/j.bbrc.2020.02.074"},{"key":"8699_CR64","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer's disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14:133\u201350.","journal-title":"Nat Rev Neurol"},{"key":"8699_CR65","doi-asserted-by":"publisher","first-page":"755","DOI":"10.18632\/aging.100504","volume":"4","author":"M Jaszberenyi","year":"2012","unstructured":"Jaszberenyi M, Rick FG, Szalontay L, Block NL, Zarandi M, Cai RZ, et al. Beneficial effects of novel antagonists of GHRH in different models of Alzheimer\u2019s disease. Aging. 2012;4:755\u201367.","journal-title":"Aging"},{"key":"8699_CR66","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nn1656","volume":"9","author":"S Diano","year":"2006","unstructured":"Diano S, Farr SA, Benoit SC, McNay EC, da Silva I, Horvath B, et al. Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci. 2006;9:381\u20138.","journal-title":"Nat Neurosci"},{"key":"8699_CR67","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1152\/physiol.00009.2025","volume":"41","author":"MH Aguiar-Oliveira","year":"2026","unstructured":"Aguiar-Oliveira MH, Boguszewski MCS, Rovaris DL, Donato J Jr. Growth hormone and IGF-1 actions in the brain and neuropsychiatric diseases. Physiology. 2026;41:0.","journal-title":"Physiology"},{"key":"8699_CR68","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s11154-024-09939-0","volume":"26","author":"RA Dulce","year":"2025","unstructured":"Dulce RA, Hatzistergos KE, Kanashiro-Takeuchi RM, Takeuchi LM, Balkan W, Hare JM. Growth hormone-releasing hormone signaling and manifestations within the cardiovascular system. Rev Endocr Metab Disord. 2025;26:397\u2013412.","journal-title":"Rev Endocr Metab Disord"},{"key":"8699_CR69","doi-asserted-by":"crossref","unstructured":"Gesmundo I, Pedrolli F, Giglioli FR, Jazaj F, Granato G, Bertoldo A, et al. Growth hormone-releasing hormone antagonists increase radiosensitivity in non-small cell lung cancer cells. Int J Mol Sci. 2025;26:3267.","DOI":"10.3390\/ijms26073267"},{"key":"8699_CR70","doi-asserted-by":"crossref","unstructured":"Zhang XL, Hartmann P. How to calculate sample size in animal and human studies. Front Med. 2023;10:1215927.","DOI":"10.3389\/fmed.2023.1215927"},{"key":"8699_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1231363","volume":"14","author":"G Granato","year":"2023","unstructured":"Granato G, Gesmundo I, Pedrolli F, Kasarla R, Begani L, Banfi D, et al. Growth hormone-releasing hormone antagonist MIA-602 inhibits inflammation induced by SARS-CoV-2 spike protein and bacterial lipopolysaccharide synergism in macrophages and human peripheral blood mononuclear cells. Front Immunol. 2023;14:1231363.","journal-title":"Front Immunol"},{"key":"8699_CR72","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40478-022-01498-2","volume":"11","author":"V Vasciaveo","year":"2023","unstructured":"Vasciaveo V, Iadarola A, Casile A, Dante D, Morello G, Minotta L, et al. Sleep fragmentation affects the glymphatic system through the different expression of AQP4 in wild-type and 5xFAD mouse models. Acta Neuropathol Commun. 2023;11:16.","journal-title":"Acta Neuropathol Commun"},{"key":"8699_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2024.102989","volume":"5","author":"D Manrique-Castano","year":"2024","unstructured":"Manrique-Castano D, ElAli A. Unbiased quantification of the spatial distribution of murine cells using point pattern analysis. STAR Protoc. 2024;5:102989.","journal-title":"STAR Protoc"},{"key":"8699_CR74","doi-asserted-by":"crossref","unstructured":"Kim J, Pavlidis P, Ciernia AV. Development of a high-throughput pipeline to characterize microglia morphological states at a single-cell resolution. eNeuro. 2024;11:ENEURO.0014-24.2024.","DOI":"10.1523\/ENEURO.0014-24.2024"},{"key":"8699_CR75","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","volume":"13","author":"M Antunes","year":"2012","unstructured":"Antunes M, Biala G. The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process. 2012;13:93\u2013110.","journal-title":"Cogn Process"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08699-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08699-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08699-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T17:02:45Z","timestamp":1779210165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08699-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8699"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08699-w","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"WS, MW and AVS are co-inventors on the patents for GHRH analogs, assigned to the University of Miami and Veterans Affairs Medical Center. The remaining authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The ethics approval for animal work was provided by the Italian Ministry of Health (protocol #1061\/2024-PR), and all procedures were authorized by the Animal Care Committee of the University of Turin. The study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statements"}}],"article-number":"494"}}